Crossmark

Metabolic resistance to the inhibition of mitochondrial transcription revealed by CRISPR‐Cas9 screen

Crossref DOI link: https://doi.org/10.15252/embr.202153054

Published Online: 2021-11-15

Published Print: 2022-01-05

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Mennuni, Mara https://orcid.org/0000-0001-6199-6233
Filograna, Roberta https://orcid.org/0000-0002-6581-9426
Felser, Andrea

Bonekamp, Nina A https://orcid.org/0000-0001-9748-8089
Giavalisco, Patrick https://orcid.org/0000-0002-4636-1827
Lytovchenko, Oleksandr https://orcid.org/0000-0003-1032-2612
Larsson, Nils‐Göran https://orcid.org/0000-0001-5100-996X
Funding

Funding for this research was provided by:

Vetenskapsrådet (2015‐00418)

Cancerfonden (2018.602)

Knut och Alice Wallenbergs Stiftelse (KAW 2016.0050)

H2020 European Research Council (2016‐741366)

Novo Nordisk Fonden (NNF20OC0063616)

Diabetesfonden (DIA2020‐516)
License Information

Version of Record valid from 2021-11-15
More Information

Publication History

Received: 2021-04-14

Accepted: 2021-10-19

Published: 2021-11-15